Skip to main content
. Author manuscript; available in PMC: 2020 Mar 27.
Published in final edited form as: Psychiatry Res Neuroimaging. 2020 Feb 11;298:111046. doi: 10.1016/j.pscychresns.2020.111046

Table 1.

Demographic and clinical measures (mean (SD)) of healthy controls (HC) and patients with OCD.

Variables HC (n=40) OCD (n=36) p
Age, years 35 (9.47) 31.83 (9.14) .14
Gender (M/F) 20/20 17/19 .89
BDI 3.05 (4.81) 21.13 (12.56) <.001*
STAI 28.32 (7.80) 47.77 (14.00) <.001*
OCI-R
             Washing
             Obsessing
             Hoarding
             Ordering
             Checking
             Neutralizing		 NA 31.47 (11.08)
5.13 (4.12)
7.97 (3.22)
3.3 (3.57)
4.72 (3.24)
5.8 (3.51)
4.52 (3.79)		 NA
OCD Onset, years NA 19.86 (9.51) NA
OCD Duration, years NA 11.7 (7.62) NA
Medication
             Fluoxetine
             Fluvoxamine
             Sertraline
             Paroxetine
             Escitalopram
             Quetiapine		 NA Sample size
2
4
2
1
6
4		 Dose, mg
40 (28.28)
122.5 (119)
200
40
41.6 (24.01)
53 (36.09)

BDI=Beck Depression Index, STAI=State-Trait Anxiety Inventory, OCI-R=Obsessive-Compulsive Inventory Revised. Age, BDI, and STAI are compared using t-test, and gender using chi-square test. Seven patients were using Escitalopram but the mean (SD) across six of them is reported here because the dose of this medication was not available for one of the patients.